Karyopharm Therapeutics Inc.401(k)
KARYOPHARM THERAPEUTICS INC. 401(K) PLAN · NEWTON, MA · plan year 2024
Peer grade: A- · admin costs + employer contributions vs same-size plans · how grading works
Karyopharm Therapeutics Inc. reported $62,878 in plan administrative expenses for 2024: 0.12% of average plan assets, below the peer median. Employer contributions averaged $8,848 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 2 years on file its reported administrative ratio fell from 0.14% to 0.12%. The plan sits in the $50M–$250M size bracket, benchmarked here against 10,352 comparable plans and shown alongside other manufacturing employers. By assets it is the 652nd-largest of 2,726 plans among Massachusetts employers on file, and the 2,912th of 13,661 in manufacturing. In 2024, employees put in $2.19 for every $1.00 the employer contributed; active participation has shrunk from 401 to 284 since 2022.
Karyopharm Therapeutics Inc.'s 2024 employer contribution ran above the $3,635 median for plans its size, placing it in the top quarter of its peers. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2024 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 263931704 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.